Nursing Home COVID-19 Vaccination Data Dashboard

Overview

Long-term care facilities (LTCF) report COVID-19 data to CDC’s National Healthcare Safety Network (NHSN), including weekly vaccination data for residents and healthcare personnel (HCP). The LTCF COVID-19 Module enables assessment of COVID-19 vaccination coverage through facility-reported information, including counts of residents and healthcare personnel, or staff, who received any COVID-19 vaccine.

CDC began collecting weekly vaccination data through the LTCF COVID-19 Module on December 14, 2020, as a voluntary reporting system. The Centers for Medicare & Medicaid Services (CMS) established COVID-19 vaccination reporting requirements for nursing homes effective May 13, 2021 (see: Federal Registerexternal icon). Detailed information about vaccination reporting requirements, including details about a grace period prior to enforcement, can be found in CMS memo QSO-21-19-NHexternal icon. The CMS reporting requirement only applies to CMS-certified nursing homes (i.e., skilled nursing facilities and/or nursing facilities).

This page displays data at the national and state level on COVID-19 vaccination coverage among residents and staff of CMS-certified nursing homes. These summaries represent data that nursing homes reported to the NHSN LTCF COVID-19 Module using weekly vaccination forms.

CDC updates the graph, “Unadjusted COVID-19 Cases Per 1,000 Nursing Home Residents, by COVID-19 Vaccination Status (including additional primary and booster doses) and Week, United States” weekly on Thursdays at 11:30am ET. The rest of the displays on this page update weekly on Thursdays by 8:00am ET. As a result, the figures presented on this page may not exactly match data publicly posted by state health departments, CMS, or other federally coordinated programs.

Additional primary and booster doses

CDC began collecting weekly vaccination data on additional primary doses and booster doses in accordance with the Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Approved or Authorized in the United States through the NHSN LTCF COVID-19 Vaccination Module on August 23, 2021. An additional primary dose refers to a subsequent dose of vaccine administered to people who likely did not mount a protective immune response after initial vaccination. An additional primary mRNA COVID-19 vaccine dose is recommended for moderately or severely immunocompromised people aged 12 years and older who received a 2-dose mRNA vaccine primary series. A booster dose refers to a subsequent dose of vaccine administered to enhance or restore protection by the primary vaccination which might have waned over time. As of January 5, 2022, CDC recommends that everyone ages 12 and older can get a booster shot.

Unadjusted COVID-19 Cases Per 1,000 Nursing Home Residents, by COVID-19 Vaccination Status (including additional primary and booster doses) and Week, United States

Download CSV excel icon[CSV – 2 KB]

Vaccination status among residents with COVID-19

Unvaccinated: Laboratory-confirmed COVID-19 and no doses of COVID-19 vaccine. Alternatively, a single-dose COVID-19 vaccine or the first dose of a 2-dose COVID-19 vaccine series received ≤ 13 days before the specimen collection date.

Primary Vaccination Series without Additional Primary/Booster Dose: Laboratory-confirmed COVID-19 ≥14 days after completing the primary series of a COVID-19 vaccine; persons in this category have not received an additional primary or booster dose or they received an additional primary or booster dose ≤ 13 days before the specimen collection date.

Additional primary/booster dose: Laboratory-confirmed COVID-19 ≥14 days after receiving an additional primary or booster dose.

Additional primary/booster dose

An additional primary dose refers to a subsequent dose of vaccine administered to people who likely did not mount a protective immune response after initial vaccination. Moderately or severely immunocompromised persons should receive an additional primary dose of the same mRNA COVID-19 vaccine administered for the primary series ≥28 days after completion of the initial 2-dose series. A booster dose refers to a subsequent dose of vaccine administered to enhance or restore protection by the primary vaccination that might have waned over time.

Incidence rate estimates

Weekly incidence rates by vaccination status were calculated as the number of cases divided by the number of residents who were unvaccinated, had complete vaccination and no additional primary or booster dose (cumulative), or had received an additional primary or booster dose (cumulative) and displayed as per 1,000 resident-weeks. The vaccination coverage data have a two-week delay compared with the case data to account for the time it takes to mount a full immune response.

Note: The rates of COVID-19 among nursing home residents are not adjusted for factors that may be associated with vaccine coverage and/or case incidence (such as community incidence or facility-level factors). Due to changes in the vaccination status of nursing home residents over time, rate denominators are not constant, and this may impact precision of rates and ability to compare rates among vaccination status groups over time.

COVID-19 Vaccination Coverage and Reporting among Residents in Nursing Homes, by Week - United States

COVID-19 Vaccination Coverage and Reporting among Residents in Nursing Homes, by State and Week - United States

Percentage of Residents in Nursing Homes with Complete COVID-19 Vaccination Receiving Additional Primary or Booster Dose, by Week – United States

Percentage of Residents in Nursing Homes with Complete COVID-19 Vaccination Receiving Additional Primary or Booster Dose, by State and Week – United States

COVID-19 Vaccination Coverage and Reporting among Staff in Nursing Homes, by Week - United States

COVID-19 Vaccination Coverage and Reporting among Staff in Nursing Homes, by State and Week - United States

Percentage of Staff in Nursing Homes with Complete COVID-19 Vaccination Receiving Additional Primary or Booster Dose, by Week – United States

Percentage of Staff in Nursing Homes with Complete COVID-19 Vaccination Receiving Additional Primary or Booster Dose, by State and Week – United States